Latest filings (excl ownership)
25-NSE
Exchange delisting
9 May 12
8-K
Tibet Pharmaceuticals, Inc. Announces Receipt of Non-Binding “Going Private” Proposal at $3.00 Per Share
1 Mar 12
8-K
Departure of Directors or Certain Officers
18 Jan 12
10-Q
2011 Q3
Quarterly report
14 Nov 11
8-K
Tibet Pharmaceuticals Announces Appointment of Sherb & Co., LLP as New Independent Auditor
18 Oct 11
8-K
Tibet Pharmaceuticals Announces Search for New Auditor Upon Resignation of ACSB
12 Sep 11
10-Q
2011 Q2
Quarterly report
15 Aug 11
8-K
Changes in Control of Registrant
10 Jun 11
10-Q
2011 Q1
Quarterly report
16 May 11
8-K
Other Events
27 Apr 11
8-K
Other Events
25 Apr 11
10-K
2010 FY
Annual report
30 Mar 11
8-A12B/A
Registration of securities on exchange (amended)
21 Jan 11
424B3
Prospectus supplement
18 Jan 11
8-A12B
Registration of securities on exchange
18 Jan 11
EFFECT
Notice of effectiveness
28 Dec 10
CORRESP
Correspondence with SEC
23 Dec 10
S-1/A
IPO registration (amended)
16 Dec 10
S-1/A
IPO registration (amended)
6 Dec 10
UPLOAD
Letter from SEC
3 Dec 10
S-1/A
IPO registration (amended)
23 Nov 10
S-1/A
IPO registration (amended)
4 Nov 10
S-1/A
IPO registration (amended)
27 Oct 10
S-1/A
IPO registration (amended)
22 Oct 10
S-1/A
IPO registration (amended)
18 Oct 10
UPLOAD
Letter from SEC
30 Sep 10
S-1/A
IPO registration (amended)
21 Sep 10
UPLOAD
Letter from SEC
31 Aug 10
S-1/A
IPO registration (amended)
16 Aug 10
UPLOAD
Letter from SEC
10 Aug 10
S-1/A
IPO registration (amended)
19 Jul 10
UPLOAD
Letter from SEC
13 Jun 10
S-1
IPO registration
14 May 10
Latest ownership filings
No filings